Purpose

This device-study includes a pilot, physiological investigation of normal human subjects. The aim is to determine how existing non-invasive neuromodulation devices affect brain circuitry as measured by EEG recording. Currently, the application of non-invasive neuromodulation is rarely guided by detailed knowledge of how neural activity is altered in the brain circuits that are targeted for intervention. This gap in knowledge is problematic for interpreting response variability, which is common. To address this gap, the current proposal aims to combine two forms of neuromodulation sequentially, transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS), to regulate homeostatic plasticity prior to rTMS delivery at different frequencies of rTMS. Homeostatic plasticity, the initial activation state of a targeted circuit, is a key determinant of whether rTMS induces long term potentiation (LTP) or long term depression (LTD) Yet, homeostatic plasticity is rarely measured or controlled in rTMS studies. We aim to control homeostatic plasticity by preconditioning the targeted circuits with tDCS prior to rTMS delivery. The protocol included an exploratory aim to examine physiological changes in patients with tinnitus but this aim was not part of the pilot physiological investigation and it could not be completed due to funding limitations.

Condition

Eligibility

Eligible Ages
Between 21 Years and 65 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • complete the informed consent process - men and women, age: 21-65 years - negative pregnancy test (female subjects of childbearing age must take a pregnancy test).

Exclusion Criteria

  • a personal or family history of epilepsy, - severe head injury, aneurysm, stroke, previous cranial neurosurgery, - sever or recurrent migraine headaches, - metal implants in the head or neck, a pacemaker, - pregnancy, - medications that lower seizure threshold,

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
This prospective, experimental design includes a block randomized, blinded, sham controlled, mixed effects model with sequential assignment to treatment arms (1 or 10 Hz rTMS) and random assignment to the tDCS conditions within each arm. The order of the three experimental conditions within each arm is randomized.
Primary Purpose
Basic Science
Masking
Double (Participant, Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
tDCS and 1 Hz rTMS delivered over TC
Participants receive sham and active 2mA tDCS over the temporal cortex (TC) prior to receiving sham and active 1 Hz rTMS (900 rTMS pulses at 110% motor threshold) delivered to the TC. .
  • Device: sham tDCS and sham rTMS
    Both combinations of tDCS and rTMS in this intervention are sham.
    Other names:
    • transcranial direct current stimulation (tDCS), repetative transcranial magnetic stimulation (rTMS)
  • Device: sham tDCS and active rTMS
    tDCS in this intervention is sham and rTMS is active
    Other names:
    • transcranial direct current stimulation (tDCS), repetative transcranial magnetic stimulation (rTMS)
  • Device: active tDCS and active rTMS
    Both combinations of tDCS and rTMS in this intervention are active
    Other names:
    • transcranial direct current stimulation (tDCS), repetative transcranial magnetic stimulation (rTMS)
Experimental
tDCS and 10Hz rTMS delivered over TC
Participants receive sham and active 2mA tDCS over the temporal cortex (TC) prior to receiving sham and active 10 Hz rTMS (900 rTMS pulses at 110% motor threshold) delivered to the TC.
  • Device: sham tDCS and sham rTMS
    Both combinations of tDCS and rTMS in this intervention are sham.
    Other names:
    • transcranial direct current stimulation (tDCS), repetative transcranial magnetic stimulation (rTMS)
  • Device: sham tDCS and active rTMS
    tDCS in this intervention is sham and rTMS is active
    Other names:
    • transcranial direct current stimulation (tDCS), repetative transcranial magnetic stimulation (rTMS)
  • Device: active tDCS and active rTMS
    Both combinations of tDCS and rTMS in this intervention are active
    Other names:
    • transcranial direct current stimulation (tDCS), repetative transcranial magnetic stimulation (rTMS)
Experimental
tDCS over DLFC and 1 Hz rTMS over TC
Participants receive sham and active 2mA tDCS over the dorsolateral frontal cortex (DLFC) prior to receiving sham and active 1 Hz rTMS (900 rTMS pulses at 110% motor threshold) delivered to the TC.
  • Device: sham tDCS and sham rTMS
    Both combinations of tDCS and rTMS in this intervention are sham.
    Other names:
    • transcranial direct current stimulation (tDCS), repetative transcranial magnetic stimulation (rTMS)
  • Device: sham tDCS and active rTMS
    tDCS in this intervention is sham and rTMS is active
    Other names:
    • transcranial direct current stimulation (tDCS), repetative transcranial magnetic stimulation (rTMS)
  • Device: active tDCS and active rTMS
    Both combinations of tDCS and rTMS in this intervention are active
    Other names:
    • transcranial direct current stimulation (tDCS), repetative transcranial magnetic stimulation (rTMS)
Experimental
tDCS over DLFC and 10 Hz rTMS over TC
Participants receive sham and active 2mA tDCS over the dorsolateral frontal cortex (DLFC) prior to receiving sham and active 10 Hz rTMS (900 rTMS pulses at 110% motor threshold) delivered to the TC.
  • Device: sham tDCS and sham rTMS
    Both combinations of tDCS and rTMS in this intervention are sham.
    Other names:
    • transcranial direct current stimulation (tDCS), repetative transcranial magnetic stimulation (rTMS)
  • Device: sham tDCS and active rTMS
    tDCS in this intervention is sham and rTMS is active
    Other names:
    • transcranial direct current stimulation (tDCS), repetative transcranial magnetic stimulation (rTMS)
  • Device: active tDCS and active rTMS
    Both combinations of tDCS and rTMS in this intervention are active
    Other names:
    • transcranial direct current stimulation (tDCS), repetative transcranial magnetic stimulation (rTMS)

Recruiting Locations

More Details

NCT ID
NCT03309696
Status
Terminated
Sponsor
University of Arkansas

Detailed Description

Background and Rationale: The current proposal aims to combine two forms of neuromodulation, transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS), to regulate homeostatic plasticity prior to rTMS delivery at two different frequencies (1Hz and 10Hz). Homeostatic plasticity, the initial activation state of a targeted circuit, is a theoretical determinant of whether rTMS induces long term potentiation (LTP) or long term depression (LTD).Yet, homeostatic plasticity is rarely measured or controlled in rTMS studies. In a physiological investigation of health subjects, we aim to control homeostatic plasticity by preconditioning the targeted circuits with tDCS prior to rTMS delivery. The justification for this study is that controlling homeostatic plasticity can reduce subject variability and the knowledge gained can be used to optimize rTMS delivery. What is needed to move the field forward is a method for combining tDCS and rTMS and for measuring neuronal responses directly which we aim to establish in this study. The pilot study project will examine the targeted effects of neuromodulation in normal subjects. The brain regions targeted for intervention include auditory areas in the temporal cortex (TC) that process sounds and functionally connected regions of the dorsolateral frontal cortex (DLFC) that mediate sensory habituation. Due to funding limitations, only the 1 Hz rTMS condition could be initiated.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.